Literature DB >> 11059805

Neurochemistry of brain neuroendocrine immune system: signal molecules.

A Galoyan1.   

Abstract

The aim of this review is not so much to show the problem of neuroendocrine, neurophysiologic, and neurochemical mechanisms of the immune system regulation of the organism by brain (there is a great deal of literature about it), as to solve the problem of whether the brain itself is an immune organ, and also to define cellular, neurochemical, and immunological properties of the brain for its immune defense when the blood-brain barrier is not damaged in spite of the penetration of the infection to brain. The accumulated literary data on CNS interaction with the immune system, expression of several cytokines and their receptors in the neurons of human brain culture, in astrocytes and microglia, all testify to the existence of a brain immune system. Recently studies appeared on the expression of major histocompatibility complex in brain neurons. It does not exclude the possibility of expression of immunoglobulins (or immunoglobulin-like proteins) in brain cells. Data obtained by us on the biosynthesis of a number of known interleukins and new cytokines in neurosecretory neurons of hypothalamus (N. Paraventricularis and N. Supraopticus) demonstrate that neuroendocrine nuclei of the hypothalamus are the center for neuroendocrine and immune systems of brain.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11059805     DOI: 10.1023/a:1007656431612

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  44 in total

1.  Protection against snake venom-induced neuronal injury by the new hypothalamic neurohormone.

Authors:  A A Galoyan; T K Kipriyan; J S Sarkissian; E J Sarkissian; Y K Grigorian; A S Andreasian; E A Chavushyan
Journal:  Neurochem Res       Date:  2000-06       Impact factor: 3.996

2.  A hypothalamic activator of calmodulin-dependent enzymes is thymosin beta 4 (1-39).

Authors:  A A Galoyan; L A Shuvalova; M T Davis; J E Shively; T D Lee
Journal:  Neurochem Res       Date:  1992-08       Impact factor: 3.996

3.  A new glycopeptide in pig, ox and sheep pituitary.

Authors:  D G Smyth; D E Massey
Journal:  Biochem Biophys Res Commun       Date:  1979-04-27       Impact factor: 3.575

Review 4.  Induction by cytokines of the pattern of pituitary hormone secretion in infection.

Authors:  S M McCann; S Karanth; A Kamat; W L Dees; K Lyson; M Gimeno; V Rettori
Journal:  Neuroimmunomodulation       Date:  1994-01       Impact factor: 2.492

5.  Purification and physico-chemical characterization of rabbit tumor necrosis factor.

Authors:  M R Ruff; G E Gifford
Journal:  J Immunol       Date:  1980-10       Impact factor: 5.422

6.  Thymosin stimulates secretion of luteinizing hormone-releasing factor.

Authors:  R W Rebar; A Miyake; T L Low; A L Goldstein
Journal:  Science       Date:  1981-11-06       Impact factor: 47.728

7.  Neuronal control of MHC class II inducibility in rat astrocytes and microglia.

Authors:  H Neumann; J Boucraut; C Hahnel; T Misgeld; H Wekerle
Journal:  Eur J Neurosci       Date:  1996-12       Impact factor: 3.386

8.  Systemic interleukin-1 alpha and interleukin-2 secretion in response to acute stress and to corticotropin-releasing hormone in humans.

Authors:  H M Schulte; C M Bamberger; H Elsen; G Herrmann; A M Bamberger; J Barth
Journal:  Eur J Clin Invest       Date:  1994-11       Impact factor: 4.686

9.  IL-2 induces vasopressin release from the hypothalamus and the amygdala: role of nitric oxide-mediated signaling.

Authors:  J Raber; F E Bloom
Journal:  J Neurosci       Date:  1994-10       Impact factor: 6.167

10.  Multiunit electrical activity in conscious rats during an immune response.

Authors:  D Saphier; O Abramsky; G Mor; H Ovadia
Journal:  Brain Behav Immun       Date:  1987-03       Impact factor: 7.217

View more
  29 in total

1.  Protective effect of a new hypothalamic peptide against cobra venom and trauma-induced neuronal injury.

Authors:  A A Galoyan; J S Sarkissian; T K Kipriyan; E J Sarkissian; E A Chavushyan; R M Sulkhanyan; I B Meliksetyan; S S Abrahamyan; Z A Avetisyan; N A Otieva
Journal:  Neurochem Res       Date:  2001-09       Impact factor: 3.996

2.  Effect of hypothalamic proline-rich-polypeptide on voltage-gated Ca2+ currents in retinal ganglion cells.

Authors:  Abram Akopian; Armen Galoyan
Journal:  Neurochem Res       Date:  2003-12       Impact factor: 3.996

3.  Glutamate-related gene expression changes with age in the mouse auditory midbrain.

Authors:  Sherif F Tadros; Mary D'Souza; Martha L Zettel; Xiaoxia Zhu; Nicole C Waxmonsky; Robert D Frisina
Journal:  Brain Res       Date:  2006-11-17       Impact factor: 3.252

4.  Neuroprotective action of hypothalamic peptide PRP-1 at various time survivals following spinal cord hemisection.

Authors:  Armen A Galoyan; John S Sarkissian; Vergine A Chavushyan; Ruben M Sulkhanyan; Zaruhi E Avakyan; Zubeida A Avetisyan; Yuri Kh Grigorian; Davit O Abrahamyan
Journal:  Neurochem Res       Date:  2005-04       Impact factor: 3.996

5.  Hypothalamic proline-rich polypeptide is an oxidative burst regulator.

Authors:  Tigran K Davtyan; Hayk M Manukyan; Gagik S Hakopyan; Nana R Mkrtchyan; Samvel A Avetisyan; Armen A Galoyan
Journal:  Neurochem Res       Date:  2005-03       Impact factor: 3.996

6.  Cytostatic effect of novel mTOR inhibitor, PRP-1 (galarmin) in MDA 231 (ER-) breast carcinoma cell line. PRP-1 inhibits mesenchymal tumors.

Authors:  Karina A Galoian; Thomas H Temple; Armen Galoyan
Journal:  Tumour Biol       Date:  2011-04-15

7.  Concepts of neuroendocrine cardiology and neuroendocrine immunology, chemistry and biology of signal molecules.

Authors:  Armen Galoyan
Journal:  Neurochem Res       Date:  2010-11-03       Impact factor: 3.996

8.  mTORC1 inhibition and ECM-cell adhesion-independent drug resistance via PI3K-AKT and PI3K-RAS-MAPK feedback loops.

Authors:  Karina Galoian; H T Temple; Armen Galoyan
Journal:  Tumour Biol       Date:  2012-01-14

9.  Proline-rich hypothalamic polypeptide has opposite effects on the proliferation of human normal bone marrow stromal cells and human giant-cell tumour stromal cells.

Authors:  R K Chailakhyan; Yu V Gerasimov; M R Chailakhyan; Armen A Galoyan
Journal:  Neurochem Res       Date:  2010-01-20       Impact factor: 3.996

10.  Proline-rich polypeptide-1 protects the cells in vitro from genotoxic effects of mitomycin C.

Authors:  R M Aroutiounian; G G Hovhannisyan; G H Gasparyan; K S Margaryan; D N Aroutiounian; N K Sarkissyan; A A Galoyan
Journal:  Neurochem Res       Date:  2009-12-01       Impact factor: 3.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.